NRC Health reported $140M of revenue over the trailing twelve months, −0.23% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $140M (to Q2 2026). Net income: $5.9M, trailing twelve months to Q2 2026. Free cash flow: $22M, trailing twelve months to Q2 2026. Operating margin: 11%, trailing twelve months to Q2 2026.

NRCNRC Health

Healthcare

$20.41+73% 1Y

$20.41

$11.2252 weeks$22.85

NRC as reported

NRC Health reported $140M of revenue over the trailing twelve months, −0.23% on the year before. 11 reported series are charted on this page, each one as filed.

$140M

Revenue, trailing twelve months · to Q2 2026 · −0.23% against the twelve months before

Net income: $5.9M
Net income · −67% year on year · trailing twelve months to Q2 2026
Free cash flow: $22M
Free cash flow · +133% year on year · trailing twelve months to Q2 2026
Operating margin: 11%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for NRC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$140M	−0.23%	Q2 2026
Net income	$5.9M	−67%	Q2 2026
EPS	$49.74	+6445%	Q2 2026
Gross margin	62%	n/a	Q2 2026
Operating margin	11%	n/a	Q2 2026
Net margin	4.3%	n/a	Q2 2026
ROE	88%	n/a	Q2 2026
ROA	7.9%	n/a	Q2 2026
ROIC	18%	n/a	Q2 2026
Free cash flow	$22M	+133%	Q2 2026
P/E	16.9	n/a	Q3 2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.